The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy.
OBJECTIVE
To evaluate the rapid parathyroid hormone assay (rPTH) as a perioperative tool in predicting postoperative symptomatic hypocalcemia following thyroidectomy.


METHODS
We conducted a prospective study of 69 patients undergoing total or completion thyroidectomy. Rapid PTH levels were obtained preoperatively, intraoperatively, and postoperatively upon arrival in the postanesthesia care unit (PACU). All patients were closely monitored postoperatively for the development of symptomatic or asymptomatic hypocalcemia.


RESULTS
Of 60 patients (25%) undergoing thyroidectomy, 15 developed hypocalcemia, 7 (11.7%) were symptomatic, and 8 (13.3%) asymptomatic. An intraoperative rPTH level less than 12 pg/mL was 71% sensitive and 95% specific for predicting postoperative symptomatic hypocalcemia, whereas a PACU rPTH level less than 12 pg/mL was 100% sensitive and 92% specific. A greater than 75% decline in preoperative rPTH level when measured intraoperatively was 71% sensitive and 86% specific, whereas a greater than 75% decline in rPTH level in the PACU was 100% sensitive and 88% specific for predicting symptomatic hypocalcemia.


CONCLUSIONS
The rPTH assay is a highly accurate and effective tool for predicting symptomatic hypocalcemia immediately after thyroidectomy. Routine utilization of this assay is recommended, because it will allow safe and timely discharge of normocalcemic patients and the early identification of patients requiring treatment of postthyroidectomy hypocalcemia.
McLeod
Ian K
IK
Department of Otolaryngology, Head & Neck Surgery, Walter Reed Army Medical Center, 6900 Georgia Avenue, NW, Washington, DC 20307, USA. ian.mcleod@na.amedd.army.mil
Arciero
Cletus
C
Noordzij
J Pieter
JP
Stojadinovic
Alexander
A
Peoples
George
G
Melder
Patrick C
PC
Langley
Roy
R
Bernet
Victor
V
Shriver
Craig D
CD
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002118:Calcium / Q000097:blood*; D002119:Calcium Carbonate / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006996:Hypocalcemia / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D007432:Intraoperative Period; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood*; D011184:Postoperative Period; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity; D013965:Thyroidectomy / Q000009:adverse effects*
D010281:Parathyroid Hormone; D002119:Calcium Carbonate; D002118:Calcium